RxDoctor Payments Data

Howard Kashefsky, DPM

Podiatrist · Durham, NCNPI 1326158494

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,900 of the $7,646 with a category attached, or 90.2%. Smith+Nephew accounts for 90.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $7,392 and has fallen 97.6% since, to $181 in 2025.

$7,646in general payments, 2019–2025

Across 11 payments — averaging $695.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$7K
  • Southtech Orthopedics$304
  • Tactile Systems Technology Inc$189
  • Integra Lifesciences Corporation$175
  • Reapplix Inc.$23
  • Nevro Corp.$17
  • plus $6 from 1 others

What the payments were for

  • Consulting fees$6,90090%
  • Food & beverage$4396%
  • Education$3074%

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,646 in reported general payments places this provider in the 85th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$39,403
Medicare patients
222
Services billed
531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate32$613
Ciclopirox15$451
Doxycycline Hyclate33$229
Ketoconazole32$211
Cephalexin13$103
Mupirocin12$62

Paid to pharmacies, not to this prescriber.

Other podiatrist in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →